nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Omeprazole—Barrett's esophagus	0.129	1	CbGbCtD
Carfilzomib—PSMB10—digestive system—Barrett's esophagus	0.038	0.243	CbGeAlD
Carfilzomib—PSMB5—smooth muscle tissue—Barrett's esophagus	0.0274	0.175	CbGeAlD
Carfilzomib—Hypomagnesaemia—Esomeprazole—Barrett's esophagus	0.0244	0.0472	CcSEcCtD
Carfilzomib—Hypomagnesaemia—Omeprazole—Barrett's esophagus	0.0244	0.0472	CcSEcCtD
Carfilzomib—PSMB1—smooth muscle tissue—Barrett's esophagus	0.024	0.153	CbGeAlD
Carfilzomib—PSMB2—smooth muscle tissue—Barrett's esophagus	0.0234	0.149	CbGeAlD
Carfilzomib—PSMB1—digestive system—Barrett's esophagus	0.0189	0.121	CbGeAlD
Carfilzomib—PSMB2—digestive system—Barrett's esophagus	0.0185	0.118	CbGeAlD
Carfilzomib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.0125	0.0242	CcSEcCtD
Carfilzomib—Hepatic failure—Omeprazole—Barrett's esophagus	0.0125	0.0242	CcSEcCtD
Carfilzomib—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.0113	0.0218	CcSEcCtD
Carfilzomib—Hyponatraemia—Omeprazole—Barrett's esophagus	0.0113	0.0218	CcSEcCtD
Carfilzomib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.0112	0.0218	CcSEcCtD
Carfilzomib—Pain in extremity—Omeprazole—Barrett's esophagus	0.0112	0.0218	CcSEcCtD
Carfilzomib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.0105	0.0204	CcSEcCtD
Carfilzomib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.0105	0.0204	CcSEcCtD
Carfilzomib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.0102	0.0198	CcSEcCtD
Carfilzomib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.0102	0.0198	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0101	0.0196	CcSEcCtD
Carfilzomib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.0101	0.0196	CcSEcCtD
Carfilzomib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00909	0.0176	CcSEcCtD
Carfilzomib—Neutropenia—Omeprazole—Barrett's esophagus	0.00909	0.0176	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00903	0.0175	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00903	0.0175	CcSEcCtD
Carfilzomib—Renal failure—Omeprazole—Barrett's esophagus	0.00852	0.0165	CcSEcCtD
Carfilzomib—Renal failure—Esomeprazole—Barrett's esophagus	0.00852	0.0165	CcSEcCtD
Carfilzomib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00774	0.015	CcSEcCtD
Carfilzomib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00774	0.015	CcSEcCtD
Carfilzomib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00766	0.0148	CcSEcCtD
Carfilzomib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00766	0.0148	CcSEcCtD
Carfilzomib—Chills—Omeprazole—Barrett's esophagus	0.00698	0.0135	CcSEcCtD
Carfilzomib—Chills—Esomeprazole—Barrett's esophagus	0.00698	0.0135	CcSEcCtD
Carfilzomib—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00664	0.0335	CbGpPWpGaD
Carfilzomib—Back pain—Omeprazole—Barrett's esophagus	0.00655	0.0127	CcSEcCtD
Carfilzomib—Back pain—Esomeprazole—Barrett's esophagus	0.00655	0.0127	CcSEcCtD
Carfilzomib—Muscle spasms—Omeprazole—Barrett's esophagus	0.00651	0.0126	CcSEcCtD
Carfilzomib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00651	0.0126	CcSEcCtD
Carfilzomib—Anaemia—Esomeprazole—Barrett's esophagus	0.00626	0.0121	CcSEcCtD
Carfilzomib—Anaemia—Omeprazole—Barrett's esophagus	0.00626	0.0121	CcSEcCtD
Carfilzomib—Leukopenia—Omeprazole—Barrett's esophagus	0.00606	0.0117	CcSEcCtD
Carfilzomib—Leukopenia—Esomeprazole—Barrett's esophagus	0.00606	0.0117	CcSEcCtD
Carfilzomib—Cough—Omeprazole—Barrett's esophagus	0.00591	0.0114	CcSEcCtD
Carfilzomib—Cough—Esomeprazole—Barrett's esophagus	0.00591	0.0114	CcSEcCtD
Carfilzomib—Hypertension—Omeprazole—Barrett's esophagus	0.00584	0.0113	CcSEcCtD
Carfilzomib—Hypertension—Esomeprazole—Barrett's esophagus	0.00584	0.0113	CcSEcCtD
Carfilzomib—Arthralgia—Omeprazole—Barrett's esophagus	0.00576	0.0112	CcSEcCtD
Carfilzomib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00576	0.0112	CcSEcCtD
Carfilzomib—Infection—Esomeprazole—Barrett's esophagus	0.00549	0.0106	CcSEcCtD
Carfilzomib—Infection—Omeprazole—Barrett's esophagus	0.00549	0.0106	CcSEcCtD
Carfilzomib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00541	0.0105	CcSEcCtD
Carfilzomib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00541	0.0105	CcSEcCtD
Carfilzomib—Anorexia—Omeprazole—Barrett's esophagus	0.00527	0.0102	CcSEcCtD
Carfilzomib—Anorexia—Esomeprazole—Barrett's esophagus	0.00527	0.0102	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00503	0.00974	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00503	0.00974	CcSEcCtD
Carfilzomib—Insomnia—Esomeprazole—Barrett's esophagus	0.005	0.00967	CcSEcCtD
Carfilzomib—Insomnia—Omeprazole—Barrett's esophagus	0.005	0.00967	CcSEcCtD
Carfilzomib—Dyspnoea—Omeprazole—Barrett's esophagus	0.00493	0.00953	CcSEcCtD
Carfilzomib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00493	0.00953	CcSEcCtD
Carfilzomib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.0048	0.00929	CcSEcCtD
Carfilzomib—Decreased appetite—Omeprazole—Barrett's esophagus	0.0048	0.00929	CcSEcCtD
Carfilzomib—Fatigue—Esomeprazole—Barrett's esophagus	0.00476	0.00922	CcSEcCtD
Carfilzomib—Fatigue—Omeprazole—Barrett's esophagus	0.00476	0.00922	CcSEcCtD
Carfilzomib—Constipation—Omeprazole—Barrett's esophagus	0.00472	0.00914	CcSEcCtD
Carfilzomib—Pain—Esomeprazole—Barrett's esophagus	0.00472	0.00914	CcSEcCtD
Carfilzomib—Pain—Omeprazole—Barrett's esophagus	0.00472	0.00914	CcSEcCtD
Carfilzomib—Constipation—Esomeprazole—Barrett's esophagus	0.00472	0.00914	CcSEcCtD
Carfilzomib—Body temperature increased—Omeprazole—Barrett's esophagus	0.00437	0.00845	CcSEcCtD
Carfilzomib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00437	0.00845	CcSEcCtD
Carfilzomib—Asthenia—Esomeprazole—Barrett's esophagus	0.00396	0.00767	CcSEcCtD
Carfilzomib—Asthenia—Omeprazole—Barrett's esophagus	0.00396	0.00767	CcSEcCtD
Carfilzomib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00382	0.0193	CbGpPWpGaD
Carfilzomib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00382	0.0193	CbGpPWpGaD
Carfilzomib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00378	0.00732	CcSEcCtD
Carfilzomib—Diarrhoea—Omeprazole—Barrett's esophagus	0.00378	0.00732	CcSEcCtD
Carfilzomib—ABCB1—epithelium—Barrett's esophagus	0.00371	0.0237	CbGeAlD
Carfilzomib—Dizziness—Omeprazole—Barrett's esophagus	0.00365	0.00707	CcSEcCtD
Carfilzomib—Dizziness—Esomeprazole—Barrett's esophagus	0.00365	0.00707	CcSEcCtD
Carfilzomib—Vomiting—Omeprazole—Barrett's esophagus	0.00351	0.0068	CcSEcCtD
Carfilzomib—Vomiting—Esomeprazole—Barrett's esophagus	0.00351	0.0068	CcSEcCtD
Carfilzomib—Headache—Omeprazole—Barrett's esophagus	0.00346	0.0067	CcSEcCtD
Carfilzomib—Headache—Esomeprazole—Barrett's esophagus	0.00346	0.0067	CcSEcCtD
Carfilzomib—Nausea—Omeprazole—Barrett's esophagus	0.00328	0.00635	CcSEcCtD
Carfilzomib—Nausea—Esomeprazole—Barrett's esophagus	0.00328	0.00635	CcSEcCtD
Carfilzomib—PSMB10—AMER1 mutants destabilize the destruction complex—APC—Barrett's esophagus	0.00294	0.0149	CbGpPWpGaD
Carfilzomib—PSMB9—AMER1 mutants destabilize the destruction complex—APC—Barrett's esophagus	0.00293	0.0148	CbGpPWpGaD
Carfilzomib—ABCB1—digestive system—Barrett's esophagus	0.00282	0.018	CbGeAlD
Carfilzomib—PSMB10—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.00271	0.0137	CbGpPWpGaD
Carfilzomib—PSMB9—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.0027	0.0136	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00245	0.0124	CbGpPWpGaD
Carfilzomib—PSMB5—AMER1 mutants destabilize the destruction complex—APC—Barrett's esophagus	0.00223	0.0113	CbGpPWpGaD
Carfilzomib—PSMB1—AMER1 mutants destabilize the destruction complex—APC—Barrett's esophagus	0.00223	0.0113	CbGpPWpGaD
Carfilzomib—PSMB2—AMER1 mutants destabilize the destruction complex—APC—Barrett's esophagus	0.00223	0.0113	CbGpPWpGaD
Carfilzomib—PSMB8—AMER1 mutants destabilize the destruction complex—APC—Barrett's esophagus	0.0022	0.0111	CbGpPWpGaD
Carfilzomib—PSMB5—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.00206	0.0104	CbGpPWpGaD
Carfilzomib—PSMB1—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.00206	0.0104	CbGpPWpGaD
Carfilzomib—PSMB2—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.00206	0.0104	CbGpPWpGaD
Carfilzomib—PSMB8—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.00203	0.0102	CbGpPWpGaD
Carfilzomib—PSMB10—Autodegradation of the E3 ubiquitin ligase COP1—TP53—Barrett's esophagus	0.00194	0.00977	CbGpPWpGaD
Carfilzomib—PSMB9—Autodegradation of the E3 ubiquitin ligase COP1—TP53—Barrett's esophagus	0.00193	0.00973	CbGpPWpGaD
Carfilzomib—PSMB10—Stabilization of p53—TP53—Barrett's esophagus	0.00191	0.00962	CbGpPWpGaD
Carfilzomib—PSMB9—Stabilization of p53—TP53—Barrett's esophagus	0.0019	0.00957	CbGpPWpGaD
Carfilzomib—PSMB10—p53-Dependent G1 DNA Damage Response—TP53—Barrett's esophagus	0.00177	0.00893	CbGpPWpGaD
Carfilzomib—PSMB9—p53-Dependent G1 DNA Damage Response—TP53—Barrett's esophagus	0.00176	0.00888	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—APC—Barrett's esophagus	0.00173	0.00875	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—APC—Barrett's esophagus	0.00173	0.00871	CbGpPWpGaD
Carfilzomib—PSMB10—G1/S DNA Damage Checkpoints—TP53—Barrett's esophagus	0.0017	0.00856	CbGpPWpGaD
Carfilzomib—PSMB9—G1/S DNA Damage Checkpoints—TP53—Barrett's esophagus	0.00169	0.00852	CbGpPWpGaD
Carfilzomib—PSMB10—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.00157	0.00793	CbGpPWpGaD
Carfilzomib—PSMB9—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.00156	0.0079	CbGpPWpGaD
Carfilzomib—PSMB1—Autodegradation of the E3 ubiquitin ligase COP1—TP53—Barrett's esophagus	0.00147	0.00741	CbGpPWpGaD
Carfilzomib—PSMB2—Autodegradation of the E3 ubiquitin ligase COP1—TP53—Barrett's esophagus	0.00147	0.00741	CbGpPWpGaD
Carfilzomib—PSMB5—Autodegradation of the E3 ubiquitin ligase COP1—TP53—Barrett's esophagus	0.00147	0.00741	CbGpPWpGaD
Carfilzomib—PSMB8—Autodegradation of the E3 ubiquitin ligase COP1—TP53—Barrett's esophagus	0.00145	0.0073	CbGpPWpGaD
Carfilzomib—PSMB1—Stabilization of p53—TP53—Barrett's esophagus	0.00144	0.00729	CbGpPWpGaD
Carfilzomib—PSMB5—Stabilization of p53—TP53—Barrett's esophagus	0.00144	0.00729	CbGpPWpGaD
Carfilzomib—PSMB2—Stabilization of p53—TP53—Barrett's esophagus	0.00144	0.00729	CbGpPWpGaD
Carfilzomib—PSMB8—Stabilization of p53—TP53—Barrett's esophagus	0.00142	0.00719	CbGpPWpGaD
Carfilzomib—PSMB1—p53-Dependent G1 DNA Damage Response—TP53—Barrett's esophagus	0.00134	0.00677	CbGpPWpGaD
Carfilzomib—PSMB2—p53-Dependent G1 DNA Damage Response—TP53—Barrett's esophagus	0.00134	0.00677	CbGpPWpGaD
Carfilzomib—PSMB5—p53-Dependent G1 DNA Damage Response—TP53—Barrett's esophagus	0.00134	0.00677	CbGpPWpGaD
Carfilzomib—PSMB8—p53-Dependent G1 DNA Damage Response—TP53—Barrett's esophagus	0.00132	0.00667	CbGpPWpGaD
Carfilzomib—PSMB10—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.00132	0.00666	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—APC—Barrett's esophagus	0.00131	0.00663	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—APC—Barrett's esophagus	0.00131	0.00663	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—APC—Barrett's esophagus	0.00131	0.00663	CbGpPWpGaD
Carfilzomib—PSMB9—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.00131	0.00663	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—APC—Barrett's esophagus	0.0013	0.00654	CbGpPWpGaD
Carfilzomib—PSMB1—G1/S DNA Damage Checkpoints—TP53—Barrett's esophagus	0.00129	0.00649	CbGpPWpGaD
Carfilzomib—PSMB2—G1/S DNA Damage Checkpoints—TP53—Barrett's esophagus	0.00129	0.00649	CbGpPWpGaD
Carfilzomib—PSMB5—G1/S DNA Damage Checkpoints—TP53—Barrett's esophagus	0.00129	0.00649	CbGpPWpGaD
Carfilzomib—PSMB10—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.00128	0.00645	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.00128	0.00644	CbGpPWpGaD
Carfilzomib—PSMB9—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.00127	0.00642	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.00127	0.00641	CbGpPWpGaD
Carfilzomib—PSMB8—G1/S DNA Damage Checkpoints—TP53—Barrett's esophagus	0.00127	0.0064	CbGpPWpGaD
Carfilzomib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00126	0.00634	CbGpPWpGaD
Carfilzomib—PSMB5—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.00119	0.00601	CbGpPWpGaD
Carfilzomib—PSMB1—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.00119	0.00601	CbGpPWpGaD
Carfilzomib—PSMB2—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.00119	0.00601	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by WNT in cancer—APC—Barrett's esophagus	0.00119	0.00599	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by WNT in cancer—APC—Barrett's esophagus	0.00118	0.00596	CbGpPWpGaD
Carfilzomib—PSMB8—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.00117	0.00593	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—RELA—Barrett's esophagus	0.00113	0.00569	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—RELA—Barrett's esophagus	0.00112	0.00566	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.00109	0.00549	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGES—Barrett's esophagus	0.00106	0.00533	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGES—Barrett's esophagus	0.00105	0.0053	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—NR1I2—Barrett's esophagus	0.00103	0.00519	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—NR1I2—Barrett's esophagus	0.00102	0.00517	CbGpPWpGaD
Carfilzomib—PSMB2—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.001	0.00505	CbGpPWpGaD
Carfilzomib—PSMB5—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.001	0.00505	CbGpPWpGaD
Carfilzomib—PSMB1—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.001	0.00505	CbGpPWpGaD
Carfilzomib—PSMB8—TCF dependent signaling in response to WNT—APC—Barrett's esophagus	0.000986	0.00498	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000981	0.00495	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling by Wnt—APC—Barrett's esophagus	0.000978	0.00494	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000976	0.00493	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling by Wnt—APC—Barrett's esophagus	0.000973	0.00491	CbGpPWpGaD
Carfilzomib—PSMB2—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.000968	0.00489	CbGpPWpGaD
Carfilzomib—PSMB5—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.000968	0.00489	CbGpPWpGaD
Carfilzomib—PSMB1—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.000968	0.00489	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000967	0.00488	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000967	0.00488	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000967	0.00488	CbGpPWpGaD
Carfilzomib—PSMB8—RNF mutants show enhanced WNT signaling and proliferation—APC—Barrett's esophagus	0.000955	0.00482	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000953	0.00481	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000899	0.00454	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000899	0.00454	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000899	0.00454	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by WNT in cancer—APC—Barrett's esophagus	0.000886	0.00447	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—RELA—Barrett's esophagus	0.000854	0.00431	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—RELA—Barrett's esophagus	0.000854	0.00431	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—RELA—Barrett's esophagus	0.000854	0.00431	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—RELA—Barrett's esophagus	0.000842	0.00425	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CYP26A1—Barrett's esophagus	0.0008	0.00404	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGES—Barrett's esophagus	0.0008	0.00404	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGES—Barrett's esophagus	0.0008	0.00404	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGES—Barrett's esophagus	0.0008	0.00404	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CYP26A1—Barrett's esophagus	0.000796	0.00402	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGES—Barrett's esophagus	0.000789	0.00398	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TP53—Barrett's esophagus	0.000783	0.00395	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—NR1I2—Barrett's esophagus	0.00078	0.00394	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—NR1I2—Barrett's esophagus	0.00078	0.00394	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—NR1I2—Barrett's esophagus	0.00078	0.00394	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TP53—Barrett's esophagus	0.00078	0.00393	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—NR1I2—Barrett's esophagus	0.000769	0.00388	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000743	0.00375	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000743	0.00375	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000743	0.00375	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—APC—Barrett's esophagus	0.000741	0.00374	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—APC—Barrett's esophagus	0.000741	0.00374	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—APC—Barrett's esophagus	0.000741	0.00374	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle Checkpoints—TP53—Barrett's esophagus	0.000733	0.0037	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—APC—Barrett's esophagus	0.000731	0.00369	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—SLC9A1—Barrett's esophagus	0.000689	0.00348	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—SLC9A1—Barrett's esophagus	0.000685	0.00346	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	0.000631	0.00318	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—GAST—Barrett's esophagus	0.000629	0.00317	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—GAST—Barrett's esophagus	0.000626	0.00316	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP26A1—Barrett's esophagus	0.000606	0.00306	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP26A1—Barrett's esophagus	0.000606	0.00306	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP26A1—Barrett's esophagus	0.000606	0.00306	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP26A1—Barrett's esophagus	0.000598	0.00302	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TP53—Barrett's esophagus	0.000594	0.003	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TP53—Barrett's esophagus	0.000594	0.003	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TP53—Barrett's esophagus	0.000594	0.003	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TP53—Barrett's esophagus	0.000585	0.00295	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—SLC9A1—Barrett's esophagus	0.000577	0.00291	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000577	0.00291	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—SLC9A1—Barrett's esophagus	0.000574	0.0029	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000574	0.0029	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SLC9A1—Barrett's esophagus	0.000522	0.00263	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—SLC9A1—Barrett's esophagus	0.000522	0.00263	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SLC9A1—Barrett's esophagus	0.000522	0.00263	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—CDKN2A—Barrett's esophagus	0.000516	0.0026	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SLC9A1—Barrett's esophagus	0.000515	0.0026	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—CDKN2A—Barrett's esophagus	0.000513	0.00259	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000488	0.00246	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—GAST—Barrett's esophagus	0.000477	0.00241	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—GAST—Barrett's esophagus	0.000477	0.00241	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—GAST—Barrett's esophagus	0.000477	0.00241	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HGF—Barrett's esophagus	0.000475	0.0024	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HGF—Barrett's esophagus	0.000473	0.00239	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—GAST—Barrett's esophagus	0.00047	0.00237	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—RELA—Barrett's esophagus	0.000454	0.00229	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—RELA—Barrett's esophagus	0.000452	0.00228	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000448	0.00226	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—SLC9A1—Barrett's esophagus	0.000437	0.00221	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—SLC9A1—Barrett's esophagus	0.000437	0.00221	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—SLC9A1—Barrett's esophagus	0.000437	0.00221	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000437	0.00221	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000437	0.00221	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000437	0.00221	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—SST—Barrett's esophagus	0.000431	0.00218	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—SLC9A1—Barrett's esophagus	0.000431	0.00217	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000431	0.00217	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—SST—Barrett's esophagus	0.000429	0.00217	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—CDKN2A—Barrett's esophagus	0.000391	0.00197	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—CDKN2A—Barrett's esophagus	0.000391	0.00197	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—CDKN2A—Barrett's esophagus	0.000391	0.00197	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—CDKN2A—Barrett's esophagus	0.000385	0.00194	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HGF—Barrett's esophagus	0.00036	0.00182	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HGF—Barrett's esophagus	0.00036	0.00182	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HGF—Barrett's esophagus	0.00036	0.00182	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HGF—Barrett's esophagus	0.000355	0.00179	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—RELA—Barrett's esophagus	0.000344	0.00174	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—RELA—Barrett's esophagus	0.000344	0.00174	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—RELA—Barrett's esophagus	0.000344	0.00174	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—RELA—Barrett's esophagus	0.00034	0.00171	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—PPARG—Barrett's esophagus	0.000339	0.00171	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—PPARG—Barrett's esophagus	0.000337	0.0017	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000327	0.00165	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SST—Barrett's esophagus	0.000327	0.00165	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SST—Barrett's esophagus	0.000327	0.00165	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SST—Barrett's esophagus	0.000327	0.00165	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—APC—Barrett's esophagus	0.000326	0.00164	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—APC—Barrett's esophagus	0.000324	0.00164	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SST—Barrett's esophagus	0.000322	0.00163	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—Barrett's esophagus	0.000287	0.00145	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—Barrett's esophagus	0.000286	0.00144	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—RELA—Barrett's esophagus	0.000276	0.00139	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000275	0.00139	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—RELA—Barrett's esophagus	0.000274	0.00138	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PPARG—Barrett's esophagus	0.000263	0.00133	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PPARG—Barrett's esophagus	0.000262	0.00132	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—PPARG—Barrett's esophagus	0.000257	0.0013	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—PPARG—Barrett's esophagus	0.000257	0.0013	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—PPARG—Barrett's esophagus	0.000257	0.0013	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—PPARG—Barrett's esophagus	0.000253	0.00128	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000248	0.00125	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTGS2—Barrett's esophagus	0.000247	0.00125	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—APC—Barrett's esophagus	0.000247	0.00125	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—APC—Barrett's esophagus	0.000247	0.00125	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—APC—Barrett's esophagus	0.000247	0.00125	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—Barrett's esophagus	0.000246	0.00124	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—APC—Barrett's esophagus	0.000243	0.00123	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGES—Barrett's esophagus	0.000235	0.00119	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—APC—Barrett's esophagus	0.000228	0.00115	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—APC—Barrett's esophagus	0.000227	0.00115	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—Barrett's esophagus	0.000217	0.0011	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—Barrett's esophagus	0.000217	0.0011	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—Barrett's esophagus	0.000217	0.0011	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—Barrett's esophagus	0.000214	0.00108	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—RELA—Barrett's esophagus	0.000209	0.00105	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—RELA—Barrett's esophagus	0.000209	0.00105	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—RELA—Barrett's esophagus	0.000209	0.00105	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—Barrett's esophagus	0.000207	0.00105	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—Barrett's esophagus	0.000206	0.00104	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—RELA—Barrett's esophagus	0.000206	0.00104	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PPARG—Barrett's esophagus	0.0002	0.00101	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PPARG—Barrett's esophagus	0.0002	0.00101	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PPARG—Barrett's esophagus	0.0002	0.00101	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PPARG—Barrett's esophagus	0.000197	0.000993	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—Barrett's esophagus	0.000187	0.000946	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—Barrett's esophagus	0.000187	0.000946	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—Barrett's esophagus	0.000187	0.000946	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—Barrett's esophagus	0.000185	0.000933	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	0.000178	0.0009	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RELA—Barrett's esophagus	0.000178	0.000899	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RELA—Barrett's esophagus	0.000177	0.000895	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—APC—Barrett's esophagus	0.000173	0.000872	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—APC—Barrett's esophagus	0.000173	0.000872	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—APC—Barrett's esophagus	0.000173	0.000872	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—APC—Barrett's esophagus	0.00017	0.00086	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—Barrett's esophagus	0.000168	0.000848	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—Barrett's esophagus	0.000167	0.000844	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—Barrett's esophagus	0.000157	0.000792	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—Barrett's esophagus	0.000157	0.000792	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—Barrett's esophagus	0.000157	0.000792	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—Barrett's esophagus	0.000155	0.000781	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000148	0.000746	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RELA—Barrett's esophagus	0.000135	0.000682	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RELA—Barrett's esophagus	0.000135	0.000682	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RELA—Barrett's esophagus	0.000135	0.000682	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RELA—Barrett's esophagus	0.000133	0.000672	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	0.000129	0.000649	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—Barrett's esophagus	0.000127	0.000642	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—Barrett's esophagus	0.000127	0.000642	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—Barrett's esophagus	0.000127	0.000642	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—Barrett's esophagus	0.000125	0.000633	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—Barrett's esophagus	0.000103	0.00052	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—Barrett's esophagus	0.000103	0.000518	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—Barrett's esophagus	7.81e-05	0.000394	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—Barrett's esophagus	7.81e-05	0.000394	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—Barrett's esophagus	7.81e-05	0.000394	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—Barrett's esophagus	7.7e-05	0.000389	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARG—Barrett's esophagus	5.87e-05	0.000296	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	4.62e-05	0.000233	CbGpPWpGaD
